Inventor · disambiguated record
Jayson M. Rieger
Also filed as: RIEGER JAYSON · RIEGER JAYSON M · RIEGER JAYSON MICHAEL
39 granted patents·19 pending applications·547 citations·filing 2002–2025
98Inventor score
Files withUNIV VIRGINIA9VERRICA PHARMACEUTICALS INC7PGX HEALTH LLC5PGXHEALTH LLC5ADENOSINE THERAPEUTICS LLC4
Top patents by PatentIndex Score
58 records- 0197US7579348B2Derivatives of 8-substituted xanthinesPGXHEALTH LLC·Filed 2006·Granted Aug 25, 2009·124 cites·47 claims
- 0295US6670334B2Method and compositions for treating the inflammatory responseUNIV VIRGINIA·Filed 2002·Granted Dec 30, 2003·62 cites·21 claims
- 0394US7598379B2Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Oct 6, 2009·14 cites·10 claims
- 0493US7605143B22-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activityUNIV VIRGINIA·Filed 2005·Granted Oct 20, 2009·25 cites·95 claims
- 0593US7576069B22-polycyclic propynyl adenosine analogs having A2A agonist activityUNIV VIRGINIA·Filed 2005·Granted Aug 18, 2009·36 cites·87 claims
- 0692US7589076B2Substituted aryl piperidinylalkynyladenosines as A2AR agonistsPGX HEALTH LLC·Filed 2007·Granted Sep 15, 2009·20 cites·43 claims
- 0792US7214665B22-propynyl adenosine analogs having A2A agonist activity and compositions thereofUNIV VIRGINIA·Filed 2002·Granted May 8, 2007·45 cites·56 claims
- 0891US11147790B2Treatment of cutaneous disordersVERRICA PHARMACEUTICALS INC·Filed 2018·Granted Oct 19, 2021·5 cites·14 claims
- 0990US7618962B2Pyrazolyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Nov 17, 2009·16 cites·59 claims
- 1089US7888329B2Substituted aryl piperidinylalkynyladenosines as A2AR agonistsPGXHEALTH LLC·Filed 2009·Granted Feb 15, 2011·12 cites·21 claims
- 1189US7737127B22-propynyl adenosine analogs having A2A agonist activity and compositions thereofUNIV VIRGINIA·Filed 2007·Granted Jun 15, 2010·12 cites·58 claims
- 1289US7732455B2Substituted 8-heteroaryl xanthinesPGX HEALTH LLC·Filed 2007·Granted Jun 8, 2010·12 cites·102 claims
- 1389US7601723B2Pyridyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Oct 13, 2009·17 cites·58 claims
- 1489US7378400B2Method to reduce an inflammatory response from arthritisUNIV VIRGINIA·Filed 2005·Granted May 27, 2008·32 cites·27 claims
- 1587US7884100B2Substituted 8-[6-amino-3-pyridyl]xanthinesPGXHEALTH LLC·Filed 2007·Granted Feb 8, 2011·9 cites·48 claims
- 1687US7442687B22-polycyclic propynyl adenosine analogs having A2A agonist activityUNIV VIRGINIA·Filed 2005·Granted Oct 28, 2008·13 cites·67 claims
- 1787US7342006B2Substituted 8-heteroaryl xanthinesADENOSINE THERAPEUTICS LLC·Filed 2004·Granted Mar 11, 2008·27 cites·55 claims
- 1887US7217702B2Selective antagonists of A2A adenosine receptorsADENOSINE THERAPEUTICS LLC·Filed 2005·Granted May 15, 2007·12 cites·86 claims
- 1986US7989431B22-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activityUniv Virginia Patent Found·Filed 2009·Granted Aug 2, 2011·6 cites·20 claims
- 2086US7875595B22-polycyclic propynyl adenosine analogs having A2A agonist activityUNIV VIRGINIA·Filed 2009·Granted Jan 25, 2011·7 cites·26 claims
- 2182US8058259B2Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT DOUGLAS·Filed 2008·Granted Nov 15, 2011·10 cites·19 claims
- 2280US8188063B2Use of adenosine A2A modulators to treat spinal cord injuryLI YUESHENG JASON·Filed 2007·Granted May 29, 2012·5 cites·21 claims
- 2375US8293720B2Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT D·Filed 2008·Granted Oct 23, 2012·2 cites·30 claims
- 2475US8252767B2Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT·Filed 2008·Granted Aug 28, 2012·2 cites·25 claims
- 2575US8153628B2Pyrazolyl substituted xanthinesWANG GUOQUAN·Filed 2009·Granted Apr 10, 2012·2 cites·40 claims
- 2673US2010166698A1New compositions and methods for the treatment of inflammationUNIV VIRGINIA·Filed 2009·Application pending·0 cites
- 2769US12233042B2Treatment of cutaneous disordersVERRICA PHARMACEUTICALS INC·Filed 2021·Granted Feb 25, 2025·0 cites·20 claims
- 2869USD900312SApplicatorVERRICA PHARMACEUTICALS INC·Filed 2017·Granted Oct 27, 2020·11 cites·1 claims
- 2968US8420813B2Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthinesWANG GUOQUAN·Filed 2009·Granted Apr 16, 2013·0 cites·1 claims
- 3066US8193200B2Antagonists of A2B adenosine receptors for treatment of inflammatory bowel diseaseSITARAMAN SHANTHI V·Filed 2007·Granted Jun 5, 2012·2 cites·2 claims
- 3166US7985754B2Selective antagonists of A2A adenosine receptorsTROVIS PHARMACEUTICALS LLC·Filed 2007·Granted Jul 26, 2011·1 cites·19 claims
- 3265USD1036656SApplicatorVERRICA PHARMACEUTICALS INC·Filed 2020·Granted Jul 23, 2024·3 cites·1 claims
- 3365US8222228B2Substituted aryl piperidinylalkynyladenosines as A2AR agonistsRIEGER JAYSON M·Filed 2010·Granted Jul 17, 2012·1 cites·8 claims
- 3465US2025332393A1Devices and methods for the treatment of body surface disordersVERRICA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3564US8263762B2Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonistsBEAUGLEHOLE ANTHONY R·Filed 2010·Granted Sep 11, 2012·2 cites·33 claims
- 3660US8501941B2Methods for the synthesis of unsymmetrical cycloakyl substituted xanthinesWANG GUOQUAN·Filed 2012·Granted Aug 6, 2013·0 cites·9 claims
- 3760US2009181920A1Intrathecal treatment of neuropathic pain with a2ar agonistsPGXHEALTH LLC·Filed 2009·Application pending·0 cites
- 3859US2025051412A1Dosing regimen for il-10 encoding expression constructXALUD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3958US2007032450A1New compositions and methods for the treatment of inflammationRIEGER JAYSON M·Filed 2006·Application pending·0 cites
- 4058US2007244134A1Selective antagonists of A2A adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2007·Application pending·0 cites
- 4157US2013109646A1Method for treating glaucoma or ocular hypertension with an adenosine derivativeSANTEN PHARMACEUTICAL CO LTD·Filed 2012·Application pending·0 cites
- 4256US12290651B2Devices and methods for the treatment of body surface disordersVERRICA PHARMACEUTICALS INC·Filed 2018·Granted May 6, 2025·0 cites·20 claims
- 4356US2010093770A1Therapeutic agent for glaucoma containing adenosine derivative as active ingredientSHIMAZAKI ATSUSHI·Filed 2008·Application pending·0 cites
- 4453US2012309774A1Selective antagonists of a2a adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2012·Application pending·0 cites
- 4551US8258142B2Substituted 8-[6-amino-3-pyridyl]xanthinesWANG GUOQUAN·Filed 2010·Granted Sep 4, 2012·0 cites·5 claims
- 4651US2011136755A12-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activityUniv Virginia Patent Found·Filed 2011·Application pending·0 cites
- 4751US2012035192A1Selective antagonists of a2a adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2011·Application pending·0 cites
- 4851US2008027022A1Method to treat gastric lesionsLINDEN JOEL M·Filed 2007·Application pending·0 cites
- 4951US2008262001A1Agonists of a2a adenosine receptors for treating recurrent tumor growth in the liver following resectionADENOSINE THERAPEUTICS LLC·Filed 2008·Application pending·0 cites
- 5048US2010273780A1Substituted 8-heteroaryl xanthinesPGXHEALTH LLC·Filed 2010·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →